GC Green Cross Selected as Preferred Negotiator for COVID-19 Vaccine Distribution

[Image source=Yonhap News]

[Asia Economy Reporter Jin-ho Kim] GC Green Cross has been selected as the top priority company for storing and distributing COVID-19 vaccines next year.

According to the pharmaceutical and bio industry on the 15th, the Public Procurement Service announced in an emergency notice for the '2022 COVID-19 Vaccine Storage and Distribution System Establishment and Operation' that GC Green Cross was chosen as the first priority bidder. The allocated budget is approximately 39.2 billion KRW. SK Bioscience is the second priority.

If the contract between the procuring agency, the Korea Disease Control and Prevention Agency (KDCA), and the first priority company fails, the negotiation rights will be transferred to the second priority company.

The company that signs the final contract with the KDCA will receive the COVID-19 vaccines imported into Korea, store and manage them in a dedicated logistics warehouse, and then deliver them to vaccination institutions while maintaining the cold chain (refrigerated distribution) from the logistics center.

This year, the domestic distribution of COVID-19 vaccines was divided between GC Green Cross and SK Bioscience.

This content was produced with the assistance of AI translation services.